GALMED PHARMACEUTICALS LTD. Operating Cash Flow
GALMED PHARMACEUTICALS LTD. (GLMD) reported Operating Cash Flow of -$4.66 million for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.95M.
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.94M.
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$1.91M.
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$1.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.66M 6-K · filed 2026-09-02 | |||
| 2025-12-31 | -$1.95M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | -$3.88M derived: sum of 2 quarters · filed 2026-03-31 | -$6.32M 20-F · filed 2026-03-31 | |
| 2025-09-30 | -$1.94M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$4.37M 6-K · filed 2025-11-26 | ||
| 2025-06-30 | -$2.44M 6-K · filed 2026-09-02 | |||
| 2024-12-31 | -$1.91M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | -$3.03M derived: sum of 2 quarters · filed 2026-03-31 | -$5.88M 20-F · filed 2026-03-31 | |
| 2024-09-30 | -$1.13M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$3.97M 6-K · filed 2025-11-26 | ||
| 2024-06-30 | -$2.85M 6-K · filed 2025-08-28 | |||
| 2023-12-31 | -$6.14M 20-F · filed 2026-03-31 | |||
| 2023-06-30 | -$3.06M 6-K · filed 2024-08-28 | |||
| 2022-12-31 | -$18.50M 20-F · filed 2025-04-02 | |||
| 2022-06-30 | -$11.36M 6-K · filed 2023-08-09 | |||
| 2021-12-31 | -$32.89M 20-F · filed 2024-04-04 | |||
| 2021-06-30 | -$16.92M 6-K · filed 2022-08-04 | |||
| 2020-12-31 | -$26.29M 20-F · filed 2023-03-29 | |||
| 2020-06-30 | -$12.84M 6-K · filed 2021-08-05 | |||
| 2019-12-31 | -$14.94M 20-F · filed 2022-05-02 | |||
| 2019-06-30 | -$7.00M 6-K · filed 2020-08-06 | |||
| 2018-12-31 | -$9.02M 20-F · filed 2021-03-18 | |||
| 2018-06-30 | -$4.91M 6-K · filed 2019-08-05 | |||
| 2017-12-31 | -$12.07M 20-F · filed 2020-03-12 | |||
| 2017-06-30 | -$6.69M 6-K · filed 2018-08-02 | |||
| 2016-12-31 | -$12.13M 20-F · filed 2019-03-13 | |||
| 2015-12-31 | -$8.47M 20-F · filed 2018-03-13 |